A detailed history of O'Shaughnessy Asset Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 5,303 shares of CTLT stock, worth $321,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,303
Previous 3,794 39.77%
Holding current value
$321,202
Previous $214,000 39.25%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $80,852 - $86,043
1,509 Added 39.77%
5,303 $298,000
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $161,472 - $226,957
3,794 New
3,794 $214,000
Q1 2022

May 13, 2022

SELL
$94.19 - $124.49 $232,837 - $307,739
-2,472 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$119.57 - $139.07 $7,174 - $8,344
-60 Reduced 2.37%
2,472 $316,000
Q3 2021

Nov 10, 2021

BUY
$109.17 - $142.35 $141,593 - $184,627
1,297 Added 105.02%
2,532 $337,000
Q2 2021

Aug 09, 2021

BUY
$100.34 - $115.69 $83,482 - $96,254
832 Added 206.45%
1,235 $134,000
Q1 2021

May 14, 2021

BUY
$101.51 - $125.27 $2,537 - $3,131
25 Added 6.61%
403 $42,000
Q4 2020

Feb 11, 2021

BUY
$85.88 - $105.36 $10,992 - $13,486
128 Added 51.2%
378 $39,000
Q3 2020

Nov 12, 2020

SELL
$72.74 - $92.5 $25,895 - $32,930
-356 Reduced 58.75%
250 $21,000
Q2 2020

Aug 13, 2020

SELL
$48.02 - $79.04 $58,680 - $96,586
-1,222 Reduced 66.85%
606 $44,000
Q1 2020

May 13, 2020

SELL
$36.95 - $62.95 $1,219 - $2,077
-33 Reduced 1.77%
1,828 $95,000
Q4 2019

Feb 12, 2020

SELL
$47.06 - $56.64 $53,366 - $64,229
-1,134 Reduced 37.86%
1,861 $105,000
Q3 2019

Nov 14, 2019

BUY
$47.45 - $58.05 $16,038 - $19,620
338 Added 12.72%
2,995 $143,000
Q2 2019

Aug 07, 2019

BUY
$39.26 - $54.21 $104,313 - $144,035
2,657 New
2,657 $144,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.9B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.